Rectal temperature and respiration rate of growing pigs
To evaluate the effects of CHS on growing pigs, the rectal temperature and respiration rate were monitored every week. As expected, rectal temperature and respiration rate increased significantly in response to CHS at 7, 14, 21 and 28 days of the trial. HMSeBA supplementation exhibited limited effect (P > 0.05) on the rectal temperature and respiration rate of pigs, however pigs received 0.6 mg Se/kg HMSeBA had a lower rectal temperature at 14, 21 and 28 d, also pigs in three HMSeBA supplementation groups had a relative lower respiration rate at 21 and 28 d (Fig. 1AB).
Effects of CHS and HMSeBA supplementation on liver weight, index and Se concentration
We investigated the effect of CHS on liver mass and Se deposition (Fig. 2). CHS decreased (P < 0.05) the absolute and relative liver weight. Dietary HMSeBA displayed a protective effect and 0.4 and 0.6 mg Se/kg HMSeBA effectively recovered the liver weight and liver weight index to normal level (Fig. 2AB). CHS alone did not affected Se concentration, while dietary HMSeBA supplementation showed a dose-dependent increase in Se deposition in liver (Fig. 2C).
Hepatic HSP70 abundance of growing pigs
The CHS affected the protein abundance of HSP70 in liver of pigs (Fig. 3). As expected, CHS significantly up-regulated the protein abundance of HSP70 in liver, which indicated pigs were suffered with heat stress. 0.4 and 0.6 mg Se/kg HMSeBA supplementation further increased (P > 0.05) HSP70 abundance compared with CHS groups.
Effects of CHS and HMSeBA supplementation on hepatic antioxidant variables
We investigated the effect of HMSeBA supplementation on antioxidant measurements in liver of pigs under CHS (Fig. 4). CHS compromised the hepatic antioxidant by decreasing (P < 0.05) GSH-Px (Fig. 4A) and increasing MDA levels (Fig. 4D). Although no statistical difference, CHS decreased (P > 0.05) T-SOD and T-AOC in liver. HMSeBA supplementation exhibited protective effect, which enhanced (P < 0.05) the GSH-Px activity in a dose dependence manner, and effectively decreased (P < 0.05) the MDA level in liver under CHS. Beyond this, HMSeBA supplementation elevated (P > 0.05) T-SOD and T-AOC in values in liver of pigs under CHS.
Effects of CHS and HMSeBA supplementation on serum biochemical and hormone
We detected the effect of CHS on blood biochemical measures and endocrine (Table 1). Pigs subjected to CHS had higher (P < 0.05) serum TBA, LDL-C, AST and lower serum F-insulin. HMSeBA supplementation moderately ameliorated (P < 0.05) the negative effect of CHS on serum AST and LDL-C. As shown in Table 1, 0.4 and 0.6 mg Se/kg HMSeBA returned (P < 0.05) serum AST activity to control level and 0.6 mg Se/kg HMSeBA reversed (P < 0.05) the serum LDL-C in pigs under CHS condition. Although CHS affected serum TBA and F-insulin concentration, dietary HMSeBA supplementation exhibited limited (P > 0.05) impact on those two biochemical indicators. CHS or dietary HMSeBA showed no impact (P > 0.05) on serum ALT, GLU, TG, CHO, HDL-C and NEFA.
Effects of CHS and HMSeBA supplementation on hepatic metabolic enzyme activity
We assessed 3 hepatic enzymes related to liver metabolism (Fig. 5). CHS disturbed hepatic glucose metabolism by decreasing (P < 0.05) the GCK level while had limited impact (P > 0.05) on PEPCK and FAS. HMSeBA supplementation recovered (P < 0.05) the liver GCK levels in a dose dependence manner and 0.4 and 0.6 mg Se/kg HMSeBA recovered the liver GCK levels to normal levels. Dietary HMSeBA had no effect on hepatic PEPCK and FAS level (Fig. 5AC).
Effects of CHS and HMSeBA supplementation on metabolism related gene mRNA and protein expression
We further investigated the response of mRNA levels of 12 metabolic related genes to HMSeBA in liver of pigs under CHS. The results showed that CHS up-regulated (P < 0.05) the mRNA levels of AMPKα1, 4E-BP1 and INSR (Fig. 6ABC), down-regulated (P < 0.05) mRNA levels of GCK, FAS and SREBP1 (Fig. 6CD) and exhibited no effect (P > 0.05) on expression of mTOR, AKT1, PCK2, IRS1, PPARG and ACC1. HMSeBA supplementation effectively prevented (P < 0.05) the up-regulation of AMPKα1, 4E-BP1 and INSR by CHS in a dose dependent manner. Meanwhile, HMSeBA supplementation reversed (P < 0.05) the down-regulation effect of CHS on GCK, FAS and SREBP1. Among them, 0.4 and 0.6 mg Se/kg HMSeBA recovered the mRNA abundance of GCK, and 0.4 mg Se/kg HMSeBA recovered the mRNA abundance of FAS and SREBP1 to normal levels. Other than that, dietary HMSeBA supplementation showed no impact on expressions of mTOR, AKT1, PCK2, IRS1, PPARG and ACC1 in liver of pigs under CHS.
We investigated protein expression of GCK in liver, the results showed that CHS inhibited (P < 0.05) the protein expression of GCK, and the decrease of GCK protein level was reversed (P < 0.05) by dietary supplementation with 0.4 and 0.6 mg Se/kg HMSeBA (Fig. 6E). AMPKα is a key protein related to metabolic signal pathway. Although CHS exposure exhibited limited impact (P > 0.05) on the protein expression of p-AMPKα, three levels of dietary HMSeBA supplementation increased (P < 0.05) its proteins abundance (Fig. 6E).
Effects of CHS and HMSeBA supplementation on mRNA and protein expression of selenoproteins
mRNA abundance of 25 selenoprotein encoding genes in liver of pigs were explored (Fig. 7). CHS increased (P < 0.05) mRNA expression of 10 selenoprotein genes (GPX1, GPX3, GPX4, SELENOS, SELENOT, SELENOP, SELENOH, SELENOI, SELENOK and SEPHS2) (Fig. 7A), decreased (P < 0.05) mRNA expression of DIO1 and SELENOM (Fig. 7B), and exhibited no effect on expression of TXNRD2, SELENOW and SELENON (Fig. 7C). Dietary HMSeBA supplementation exhibited impact on expression of selenoprotein encoding genes in liver of pigs under CHS, which decreased (P < 0.05) expression of GPX3, GPX4, SELENOS, SELENOT, SELENOP, SELENOH, SELENOI, SELENOK, SEPHS2, DIO1, and SELENOM)(Fig. 7A) and increased (P < 0.05) the mRNA abundance of DIO1 and SELENOM (Fig. 7B). CHS did not affected the expression of TXNRD2, SELENOW and SELENON, while dietary 0.2 or 0.4 mg Se/kg HMSeBA supplementation increased (P < 0.05) their expression in liver of pigs under CHS (Fig. 7C). Additionally, CHS or dietary HMSeBA did not affected expression of SELENOF, TXNRD1, SELENO and MSRB1. Taken together, HMSeBA supplementation alleviated the impact of CHS on expression of selenoprotein encoding genes in liver of pigs, 0.4 or 0.6 mg Se/kg dietary HMSeBA supplementation exhibited better recovery effect based on the expression of these selenoprotein encoding genes, which shared similar mRNA profiles compared with that of the control.
We also investigated protein expression of 3 selenoproteins (Fig. 8). CHS affected expression of selenoproteins, which inhibited (P < 0.05) the protein expression of GPX4 and SELENOS. HMSeBA supplementation inhibited (P < 0.05) this CHS induced reduction and the protein expression of GPX4 was enhanced (P < 0.05) with the increased of HMSeBA supplementation. Also, the decreased SELENOS was reversed (P < 0.05) in CHS + 0.2HMSeBA group and enhanced (P < 0.05) expression in CHS + 0.4HMSeBA group. CHS did not affected the expression of GPX1, while three levels of dietary HMSeBA supplementation greatly increased (P < 0.05) its protein expression in liver of pigs under CHS.